11/07/2025
🔬 Why a Risk-Based Approach to Biocompatibility Saves You Time and Money
Is more testing always better? Not when it comes to biocompatibility.
A risk-based approach — as recommended by ISO 10993-1 and MDR — helps manufacturers avoid unnecessary testing, focus resources where risks actually exist, and streamline regulatory submissions.
In our latest article, we explain:
💡 How to build a risk-based biocompatibility strategy
💡 Why chemical characterization is key
💡 How this approach leads to faster market approvals
Learn why smart planning is more powerful than excessive testing.
👉 Read the full article here:
https://ebi.bio/why-a-risk-based-approach-to-biocompatibility-saves-you-time-and-money/
hasztag hasztag hasztag hasztag hasztag hasztag
This link will take you to a page that’s not on LinkedIn